Cancer Research Journal

Volume 3, Issue 6, November 2015

  • Bioequivalence of Two Formulations (Innovator vs Generic) of Capecitabine in Patients with Cancer of Colon

    Ruiz-García Erika Betzabe, Mancera-Reyes Víctor Manuel, Bustillos-Ventura Rafael, Cárdenas José Manuel, Canales-Vázquez Emmanuel, Meixueiro-Montes de Oca Raúl

    Issue: Volume 3, Issue 6, November 2015
    Pages: 110-114
    Received: Oct. 22, 2015
    Accepted: Nov. 04, 2015
    Published: Dec. 08, 2015
    Abstract: Capecitabine is an orally administered chemotherapeutic agent used in the treatment of numerous cancers including colon, colorectal, ovarian, breast and pancreatic. Considering the importance of generic drugs in Health Care Systems, it is essential that its quality, safety and efficacy be compared with the corresponding innovator product. The objec... Show More